Elucidating the precise pharmacological mechanism of action (MOA) of naturally occurring compounds is often demanding. Even though Tarselli et al. (60) developed the first de novo artificial pathway to conolidine and showcased that this naturally developing compound correctly suppresses responses to the two chemically induced and inflammation-derived pain, the https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers